BEAT Price Target
| Recent BEAT Price |
|
BEAT Price Target |
| $2.01 |
+237.31% |
$6.78 |
As of 2024-05-10
| Recent BEAT Analyst Ratings Breakdown |
| |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong buy ratings: |
1 |
1 |
2 |
2 |
| Buy ratings: |
0 |
0 |
0 |
0 |
| Hold ratings: |
0 |
0 |
0 |
0 |
| Sell ratings: |
0 |
0 |
0 |
0 |
| Strong sell ratings: |
0 |
0 |
0 |
0 |
| Average rating: |
1.0 |
1.0 |
1.0 |
1.0 |
The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is
Strong Sell. For the
BEAT price target at the top of this page, we present the average BEAT target price
across the 2 analysts covering BEAT, as reported in
data provided by Zacks Investment Research via Quandl.com. The
median BEAT price target (a different metric than the
average or
mean) was $6.775 as of 2024-05-10, the
highest BEAT price target in the range was $8.0 while the lowest BEAT price target in the range was
$5.55, with a standard deviation of $1.732.
Get the latest Zacks research report on BEAT — FREE
10 ETFs With Most Upside
To Analyst Targets
Top 25 Broker Analyst Picks of the
S&P 500
For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the
ETF as far as deciding whether to continue to hold the stock. ETFs by nature are passive index-followers, so as long as the
stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Below are some
of the ETFs that hold BEAT at last report:
| ETF |
BEAT Weight |
BEAT Amount |
| VTI |
0.00% |
$748,145 |
| VXF |
0.00% |
$356,739 |
|
| Company Name: |
| Heartbeam Inc |
| Sector: |
| Medical Instruments & Supplies |
| Number of ETFs Holding BEAT: |
| 2 |
| Total Market Value Held by ETFs: |
| $1,104,884 |
| Total Market Capitalization: |
| $55,000,000 |
| % of Market Cap. Held by ETFs: |
| 2.01% |
|
Strong Buy (4.00 out of 4)
97th percentile
|
ETFChannel.com
Free BEAT Email Alerts:
